TESARO, Inc.

TESARO, Inc.

TESARO, Inc.

TESARO is a biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer.
Founded
2010
Raised
$366M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$50,000,000
Post-IPO equity - 2016
$155,000,000
Post-IPO equity - 2016
Team Size
50+
Employees
PE HUB

GSK slides after buying cancer firm Tesaro for hefty $5.1 billion: Reuters

MedCity News

GlaxoSmithKline to buy cancer-focused Tesaro for $5.1 billion

Xconomy

Manufacturing Issues Stall Tesaro Cancer Nausea Drug at FDA

Robotics Health
Xconomy

Tesaro Stock Sale Hauls in $409M on Heels of Strong Cancer Data

Health